JCOG2002: A randomized phase III study of thoracic radiotherapy for extensive stage small cell lung cancer. Sacituzumab tirumotecan (SKB264/MK-2870) in combination with KL-A167 (anti-PD-L1) as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results